A new study suggests that restoring the balance of a protein in the blood could be a promising treatment option for systemic lupus erythematosus, also known as lupus, an untreatable autoimmune disease.
Type I interferon (IFN) is a strong immune activator found in high concentrations in the majority of patients with lupus, an autoimmune disease. In Arthritis & Rheumatology, researchers report positive results from the first placebo-controlled long-term trial of anifrolumab, a human mon